Tyagi Asha, Deep Sonali, Salhotra Rashmi, Malhotra Rajeev, Singla Anshuja
Department of Anaesthesiology and Critical Care, University College of Medical Sciences and GTB Hospital, Delhi, India.
Biostatistician, Delhi Cancer Registry, Dr. BRAIRCH, All India Institute of Medical Sciences, Delhi, India.
Indian J Anaesth. 2023 Aug;67(8):690-696. doi: 10.4103/ija.ija_760_22. Epub 2023 Aug 15.
There are scanty data for oxytocin dose in patients at high risk of uterine atony. We aimed to compare the effective dose (ED) 90 of oxytocin for adequate uterine tone during the caesarean section in patients at high-risk vs low-risk uterine atony.
This dose-finding study was undertaken after ethical approval in non-labouring women aged >18 years with pre-defined risk factors for uterine atony (high-risk group) vs those without such factors (low-risk group) ( = 39 each). Starting dose of oxytocin in the first patient of low-risk and high-risk groups was 1 and 3 IU, respectively. Achieving adequate uterine tone at 3 min of oxytocin bolus was designated 'success', while inadequate tone constituted 'failure'. If the response was 'failure', the dose of oxytocin was increased for the next patient by 0.5 or 0.2 IU (high- and low-risk groups, respectively). In case of a successful response, the dose for the next patient was decreased with a probability of 1/9 using the same dosing intervals or otherwise kept unchanged.
The ED90 (95% CI) of oxytocin bolus was 4.7 (3.3-6.0) IU for the high-risk group and 2.2 (1.3-3.2) IU for the low-risk group ( = 0.044). Oxytocin-associated tachycardia ( = 0.247) and hypotension ( = 0.675) were clinically greater for the high-risk vs low-risk group but statistically similar.
Non-labouring patients with high-risk factors for uterine atony require a greater dose of initial oxytocin bolus to achieve adequate uterine tone during the caesarean section compared to those without risk factors.
关于子宫收缩乏力高危患者使用催产素剂量的数据较少。我们旨在比较高危与低危子宫收缩乏力患者剖宫产术中达到足够子宫张力时催产素的有效剂量(ED)90。
本剂量探索研究在获得伦理批准后,纳入年龄大于18岁、有预先定义的子宫收缩乏力风险因素的未临产女性(高危组)和无此类因素的女性(低危组)(每组n = 39)。低危组和高危组第一名患者的催产素起始剂量分别为1 IU和3 IU。催产素推注3分钟时达到足够子宫张力被定义为“成功”,而子宫张力不足则为“失败”。如果反应为“失败”,高危组和低危组下一名患者的催产素剂量分别增加0.5 IU或0.2 IU。如果反应成功,下一名患者的剂量以1/9的概率使用相同的给药间隔降低,否则保持不变。
高危组催产素推注的ED90(95%CI)为4.7(3.3 - 6.0)IU,低危组为2.2(1.3 - 3.2)IU(P = 0.044)。高危组与低危组相比,催产素相关的心动过速(P = 0.247)和低血压(P = 0.675)在临床上更常见,但在统计学上相似。
与无风险因素的患者相比,有子宫收缩乏力高危因素的未临产患者在剖宫产术中需要更大剂量的初始催产素推注以达到足够的子宫张力。